Physician profile
Felix Sterling
NPI 1801066907
$6,207.82
in general payments reported to CMS, 2019-2025
20 companies · $205 in 2025
The $205 reported for 2025 was more than what a typical Child & Adolescent Psychiatry provider received nationally (typical 2025 total: $132).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,829 · 2020: $796 · 2021: $1,703 · 2022: $874 · 2023: $501 · 2024: $301 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,006.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,006.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $1,308.59 | 2019-2025 | Rexulti, Abilify Asimtufii, Abilify Maintena |
| Merck Sharp & Dohme LLC | $1,153.00 | 2021 | |
| Alkermes, INC. | $1,046.33 | 2019-2024 | Lybalvi, Aristada |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $573.48 | 2022-2023 | |
| Neurocrine Biosciences, INC. | $513.71 | 2022-2023 | Ingrezza |
| Amgen INC. | $374.97 | 2020-2021 | |
| Lundbeck LLC | $276.30 | 2019-2020 | |
| Abbvie INC. | $232.98 | 2021-2023 | Vraylar |
| Janssen Pharmaceuticals, INC | $163.35 | 2019-2024 | Invega Sustenna |
| E.R. Squibb & Sons, L.L.C. | $154.68 | 2024-2025 | Cobenfy |
| Teva Pharmaceuticals USA, INC. | $141.00 | 2021-2023 | Austedo |
| Biohaven Pharmaceuticals, INC. | $70.61 | 2020 | |
| Abbott Laboratories | $49.23 | 2022-2023 | Thoratec Heartmate 3 Lvas Implant Kit |
| Bridgebio Pharma, INC. | $48.28 | 2025 | Attruby |
| Avanos Medical | $24.68 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biocompatibles, INC. | $17.45 | 2019 | |
| Amryt Pharma Holdings LTD | $16.38 | 2022 | |
| Lilly USA, LLC | $15.00 | 2022 | |
| Allergan, INC. | $15.00 | 2019 | |
| Altathera Pharmaceuticals LLC | $12.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Felix Sterling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.